Dual Diagnosis | Addiction Conference | Mental Health | Neurology | Munich | Germany | Europe | Asia | Middle East

Theme: Research strategies, advanced technologies and innovations in Dual Diagnosis

Dual Diagnosis 2017

Scientific Program

Renowned Speakers

Charles Graham
Community College of Aurora
USA

Kam Tim Michael Chan
Vice President of the Association of Integrative Aesthetic Medicine
Hong Kong

Vahid Farnia
Kermanshah University of Medical Sciences
Iran

Esmeralda Thoma
University of Medicine of Tirana
Albania

Kaufui Vincent Wong
University of Miami
USA

J T McDevitt
Rice University, USA
USA

Norman S Miller
Health Advocates PLLC, USA
USA

Thersilla Oberbarnscheidt
Central Michigan University, USA
USA

Michael Groat
The Menninger Clinic-Baylor College of Medicine, USA
USA

Nachum Dafny
University of Texas Health Science Center at Houston, USA
USA

Kun-Hua Lee
Yuli Hospital, Taiwan
Taiwan

Diane Mintz
Mental Health Advocate & Business Owner, USA
USA

Melissa Alton
LMHC, NCC, CCMHC, EMDR in Private Practice, USA
USA

Deanna L Mulvihill
TLI Foundation, USA
USA

Helen Northcott
Choose a Lifestyle, Canada
Canada

Jacqueline Heron
Toronto Western Hospital, Canada
Canada

Linda Lane Devlin
Success on line coaching & Interventions on demand, Canada
Canada

Suhera M Aburawi
University of Tripoli, Libya
Libya

Adi Jaffe
Alternatives Behavioral Health LLC, USA
USA

Stephen R Sroka
Western Reserve University, USA
USA

Zohreh Zarnegar
University of Southern California, USA
USA

Patricia Kelley
The ChangeTeacher.com, USA
USA

Terrence Shulman
The Shulman Center for Compulsive Theft Spending and Hoarding
USA

Prapapun Chucharoen
Mahidol University
Thailand

Gina H Tabrizy
Harmony Heals Holistic Counseling Center
USA

Anna Moszczynska
Wayne State University
USA

Elizabeth Halpern
Central Navy Hospital in Rio de Janeiro
Brazil

Kjetill Hustoft
Stavanger University Hospital
Norway

Edward Korzus
University of California Riverside
USA

David E McCauley
Oak valley Foundation
USA

Dual Diagnosis 2017

We are proud to welcome you to The 2nd International Conference and Exhibition on Dual Diagnosis which is going to be held during May 18-19, 2017 in Munich, Germany with a root motif “Research strategies, advanced technologies and innovations in Dual Diagnosis" which is a cornerstone for accomplishing Addiction Rehabilitation and psychiatry problems. Dual Diagnosis 2017 will extend an opportunity for all marketing societies working on addiction and comorbid psychiatric disorders to exhibit their work.

Dual Diagnosis conference will assemble illustrious speakers, Researchers, Nobel laureates, Neurologists, and Psychiatry researchers from both academic and health care professionals will join this event to discuss their views and research. The event will be organized by world addiction and psychiatry experts for conducting symposiums, B2B meetings, and workshops will also be conducted on the field of Dual Diagnosis therapy, Addiction Rehabilitation, Alcohol Rehabilitation, Addiction treatment, Dual Diagnosis treatment, Mental illness and, Psychiatric disorders.

Track 01: Drug Addiction

Addictions are chronic, deteriorate brain disorders and identified by drug seeking and abuse. Addiction changes the brain functioning. Those drugs effects human brain is much harmful, and often self-destructive. Abuse and Alcohol Rehabilitation to drugs cost Americans more than $800 billion per year. Illicit, prescription drugs and alcohol causes the death of around 90,000 Americans, while tobacco with 480,000 deaths. Addiction Rehabilitation is a central nervous system depressant; it slows down mental and bodily processes. American association of Dual Diagnosis reveals that alcohol addiction may experience a decrease in feelings of anxiety or stress.

11th World Congress on Neurology and Therapeutics March 27-29, 2017 Madrid, Spain: 10th International Conference on Neuroscience and Neurochemistry February 27-28, 2017 Amsterdam, Netherlands: 3rd International Conference on Neurological Disorders and Stroke April 24-26, 2017 Dubai, UAE: 2nd Annual 2nd International Conference on NeuroRehabilitation May 25-26, 2017 Chicago, USA: 47^th Addiction Medicine Conference June 14-17, 2017 Hilton Baltimore, Baltimore, Australian and New Zealand Addiction Conference May 18-20 2017 Gold Coast, Australia, 18^th Addiction Therapy conference June 1-2, 2017, Miami, USA, Addiction Medicine Conference June 22^nd and 25th 2017 Asheville, USA, 8^th Cognitive Behavioural Therapies Conference June 22-25, 2017 Melbourne, Australia,

Track 02: Addiction & Brain

Psychiatry focuses on the diagnosing, treatment, and hindrance of psychological state and emotional issues. We will understand the body's functions and also the advanced relationship between emotional malady and alternative medical malady. Psychological state skilled and doc will distinguish between physical and psychological causes of each mental and physical disorders Scientist’s area unit developing interventions exploitation pharmacological and behavioral treatments in alcohol and chemical dependence and addiction rehabilitation.

6th International Conference on Vascular Dementia February 27th - March 01st, 2017 Amsterdam, Netherlands: 11th World Congress on Neurology and Therapeutics March 27-29, 2017 Madrid, Spain: 2nd International Conference on Neuro Oncology and Brain Tumour April 24-25, 2017 Dubai, UAE: International Conference on Inorganic Chemistry April 27-28, 2017 Las Vegas, USA: 2nd Annual Experts Meeting on Depression, Anxiety and Stress Management November 07-08, 2016 Barcelona, Spain: 2nd International conference on Osteoporosis and Musculoskeletal Disorders May 22-24, 2017 Mexico, USA: 7th International Conference on Dementia and Care Practice May 04-05, 2017 Toronto, Canada: Addiction Medicine Conference June 22^nd and 25th 2017 Asheville, USA, 8^th Cognitive Behavioural Therapies Conference June 22-25, 2017 Melbourne, Australia,

Track 03: Mental Health & Addiction

Mental disorders with complications brought through alcohol or substance abuse. Dual diagnosis can be challenging to distinguish and diagnose because the use of medicine can often carry medical specialty symptoms that build it arduous to differentiate from a pre-existing disorder. Since this condition requires attention for abuse as well as psychopathy, a dual diagnosis scenario most frequently is additional complicated than these conditions independent diagnosed with Dual Diagnosis therapy area unit at a better risk for substance dependency of marijuana, opiates, and cocaine and alternative stimulants and alcohol and other people.

Track 04: Opioids Poisoning

Addiction Treatment, such as methadone, buprenorphine, and naltrexone (including a new long-acting formulation), are available for individuals addicted to opioids, Drug dependence is associate degree adaptive state that results from continual drug usage, and which ends up in withdrawal upon stopping drug use. Dependency may be a totally different criterion from substance dependence, associate degree addictive, unconditional drug use, and results severe issues. Associate degree addictive drug will functions on appreciated and reinforcing systems.

Track 05: Addiction & Neurotoxicology

According to American Association of Dual Diagnosis Alcohol and alternative medication of abuse have vital impacts on the neuroimmune system. Studies have incontestable that medication of abuse move with the Addiction Rehabilitation and alter neuroimmune organic phenomenon and signalling, that successively contribute to numerous aspects of addiction. Because the key part of the central nervous system. These neuromodulator properties of immune factors, alongside their essential role in neuroinflammation, give a replacement framework to know neuroimmune mechanisms mediating brain purposeful and activity changes tributary to addiction. This chapter highlights recent advances in understanding hard drug.

Track 06: Addictive Disorders

Addictive disorder could be a medicine chronic destruction of brain reward system, motivation, and memory. Results in inability to regulate behaviour, results in habitual changes, and that affect someone from recovery of substance. Reason for habit-forming disorder is habit or activity that offers America pleasure and a genetic variance that will increase our interest. Addiction therapy is genetically developed in our psychological system, social and environmental factors that cause excessive and prolonged usage, tolerance and withdrawal and negative consequences.

Track 07: Addiction Psychiatry

American Association of Dual Diagnosis reveals to grasp the character and extent of white plague, drug abuse, dependence, and associated risk and protecting factors. Round the world, 17.3 million individuals have drug use disorders. Within the year 2012, around 3.3 million deaths, were known thanks to alcohol consumption. In 2008, 3.5% to 5.7% of the world's population aged 15-64, used non-prescribed psychedelic medication. Globally cannabis usage is seen in 129-190 million individuals, next is amphetamines, cocaine and opioids. In step with the yank Medical Association thirteen.5 capitalize on the U.S. population has a substance abuse Disorder.

The biology of addiction treatment encompasses quite the neurochemistry of reward. The cortical region of the brain and underlying substantial Alba connections between the cortical region and circuits of reward, motivation and memory are basic within the manifestations of altered impulse management, altered judgment, and therefore the dysfunctional pursuit of rewards seen in addiction despite accumulative adverse consequences toughened from engagement in substance use and alternative habit-forming behaviours.

Track 08: Bipolar Disorder

Bipoalar disorders may call as manic-depressive sickness that involves mania and depression. In such cases mood changes from low to high and back again square measure dramatic and rapid, but additional often they are gradual and slow, and intervals of normal mood may occur between the manic and depressive phases of the condition. The symptoms of depressive and manic cycles may be severe and infrequently lead to impaired functioning. In any given year, manic-depressive psychosis affects more than 2 of American adults. About 5.7 million American adults, or about 2.6 % of the population aged 18 and older, have emotional disorder.

Track 09: Depression & Anxiety

Most people feel anxiety or depressed occasionally with Addiction. Losing a beloved, getting unemployed from a job, going through a divorce, and alternative troublesome things can lead an individual to feel unhappy, lonely, scared, nervous, or anxious. These feelings are normal reactions to lives under pressure. However some individuals experience these feelings daily or nearly daily for no apparent reason, creating it difficult to hold on with normal, everyday functioning. These individuals might have a mental disorder, depression, or both. Major depression may be a treatable malady that affects the approach an individual thinks, feels, behaves, and functions. At any point in time, three to five of individuals suffer from major depression; the time period risk is concerning terrorist organization 17%.

Track 10: Clinical Interventions & Case Reports

Recent clinical studies have shown that between half-hour and hour of drug abusers have mental state diagnoses Depression, schizophrenic psychosis, and manic disorders. Drug addiction may be a typical of disorder involves the interaction of environmental factors and genetic factors to extend the susceptibility of an individual to addictive behaviour. SAMHA scientist’s area unit working on the pharmacological and neuropsychosocial models and approaches that involve pre-symptomatic studies and clinical findings, to elucidate the results of mental health and physical disorders and outcomes in drug-addicts, Researchers specialize in pregnant women smokes cigarettes. Tobacco usage elevates therapeutic and behavioral therapies in smokers with synchronous psychiatrically disorders.

Track 11: Science of Drug abuse

Drug abuse is over use drug wherever the user intakes the substance in Brooding again amount that is harmful. Alcohol, amphetamines, barbiturates, benzodiazepines, cocaine, cannabis and opioids are usually used medication in abuse. Addiction rehabilitation approved for treatment is replacement therapies like buprenorphine and dolphin hydrochloride. Reports justify that forty three.7 million Americans ages fifteen seasoned mental state. Within the past year, 25.7 million adults had a substance use disorder. In those 8.4 million folks had each a disorder and substance use disorder, additionally referred to as co-occurring mental and drug use disorders.

Track 12: Neuro Cognitive disorders

The Neurocognitive Disorders Work Group of the American Psychiatric Association's DSM-5 Task Force began work in April 2008 on their task of proposing revisions to the criteria for the disorders referred to in DSM-IV as Delirium, Dementia, Amnestic and Other Cognitive Disorders. Mood disorders are common psychiatric illnesses that represent a major cause of disability and mortality worldwide. It is estimated that 8% to 20% of the population will experience a depressive episode at some point in their lives. Of those individuals with symptoms so severe as to require hospitalization, 15% will go on to commit suicide.

Track 13: Addiction Nursing

Substance Abuses Nurses are specialized in pain management, and help regulate treatment for patients addicted to drugs, alcohol, and other substances. Much of their job also involves teaching patients about the dangers of substance abuse and possible treatment options. Since addiction is both a mental and physical disease, these nurses are trained in both general medicine and mental health. As a Substance Abuse Nurse, you’ll be able to give support to people with little else in their lives besides addiction.

Track 14: Addiction: Pharmacology

Studies on the pharmacology of addiction focus on the properties of addictive drugs as they interact with the brain and on potential drug treatments for addiction. Some of this research overlaps with genetic research, as, for example, in studies using knock-out mice. The use of noninvasive brain imaging techniques such as positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) allows researchers to watch how the brain responds to doses of a drug. Currently, few medications are effective in treating addiction, and that is a major focus of research.

Track 15: Addiction Therapy

Dual diagnosis is the condition of suffering from an addictive disorder and a co-occurring misuse problem. Any patient will have a "dual diagnosis" associated for an addiction disorder will have a “co-occurring mental disorder”. Identification a primary psychiatrically sickness in substance abusers is difficult as drug abuse itself typically induces medical specialty issues, therefore creating it necessary to differentiate between drug iatrogenic and pre-existing psychopathy. Addiction treatment, as well as alcohol and prescribed drugs, will induce symptoms which resembles psychopathy.

Addiction therapy is meant to assist inveterate people stop compulsive drug seeking and use. Drug treatment will embrace behavioural medical aid like cognitive-behavioral medical aid or contingency management, medications. Behavioural therapies will facilitate encourage individuals to participate in drug treatment, provide ways for managing drug cravings, teach ways in which to avoid medicine and stop relapse, and facilitate people touch upon relapse if it happens.

Track 16: Dual Diagnosis Rehabilitation & Recovery

Drug rehabilitation could be a medical or Psychotherapeutic treatment of dependency for mind-bending substances like addictive medication, alcohol and fatal medication like amphetamines opiate and cocaine. The general committed is to alter the patient to stop drug abuse to avoid the monetary, legal, psychological, social, and consequences that effects physically. Dual Diagnosis treatment centres embody meditation and non-secular knowledge within the treatment method. Within the U.S.A, it's calculable that 25-40 million individuals square measure in recovery.

Medication normally thought of capable of recreational use embrace ethyl alcohol, cannabis, nicotine, caffeine, and substances among the scope of the United Nations' Single Convention on Narcotic medication. American Association of Dual Diagnosis, in 2012 it had been calculable that concerning third to six of individuals use non-legal medication. Hallucinogenic Substances Domestic and jurisprudence social control agencies square measure occupied with interdiction efforts against contraband drug use, production, and circulation. Narcotic use is use of a drug with the first intention to change the state of consciousness so as to make positive emotions.

On behalf of Dual Diagnosis 2017 Organizing Committee, we cordially invite addiction expertise, professors, scientific communities, therapists, counsellors, students and business delegates to attend the 2^nd International Conference and Exhibition on Dual Diagnosis which is to be held on May 18-19, 2017 Munich, Germany. Main theme of the conference is “Research strategies, advanced technologies and innovations in Dual Diagnosis”.

Dual Diagnosis 2017 focuses on the latest advancements in addiction research and treatment, explaining about various addiction sources making the audience to understand the alteration caused in human behaviour and psychological activities by various addiction disorders. This two day event provides a perfect platform for leading scientists, researchers, decision-makers and other players to gain the latest information on topics of current research like addiction genetics, drug addiction, dual diagnosis, neurotoxicology, and drug induced brain disorders and new insights in addiction treatment & rehabilitation and their significance in clinical research and health diagnostics.

Why to attend?

The Conference will encourage new discoveries and research by providing a platform for reporting of unique and unusual cases which enhance understanding of disease process, its diagnosis, management and clinico-pathologic correlations. It will provide a podium for wide-ranging aspects of psychological, neurological, molecular, genetic and behavioural pathways underlying addiction, and will focus on novel therapies providing quality care for people with unhealthy alcohol, tobacco, or other drug use and addictive behaviors across a spectrum of clinical settings. It will comprise of opening Keynote lectures by the renowned researcher and noble members working in the field of addiction research and treatment followed by the special workshop and symposium sessions by eminent scholars and therapeutic members for all the two days of the conference.

The previous conferences on Addiction Research & Therapy (Addiction Therapy 2014, Addiction Therapy 2015) which were held at Chicago and Georgia, USA have explained new strategies and advanced therapeutic aspects in addiction treatment that have gained much interest from eminent scientists all over the world.

Conference series LLC organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Target Audience:

Addiction researchers and expertise

Addiction faculty

Psychiatrists

Psychologists

Therapists & Addiction counselors

Addiction students, scientist

Treatment Centers and Rehabilitation Houses

Relevant Association and Societies

Medical college

Business professionals (Directors, presidents, CEO) from addiction pharmacotherapy market

Dual Diagnosis 2017 welcomes attendees, presenters, and exhibitors from all over the world to Munich, Germany. We are delighted to invite you all to attend and register for the “2^nd International Conference and Exhibition on Dual Diagnosis” which is going to be held during May 18-19, 2017. The organizing committee is gearing up for an exciting and informative conference program including Keynote presentation, plenary lectures, symposia, workshops and poster presentations on various topics related to addiction research and therapy around the theme Research strategies, advanced technologies and innovations in Dual Diagnosis for participants from all over the world.

Importance and Scope:

Dual Diagnosis 2017 is a two day event provides a perfect platform for leading scientists, researchers, decision-makers and other players to gain the latest information on topics of current research like Addiction Genetics, Drug addiction and Neuro toxicology, Dual Diagnosis and Drug induced brain disorders.

The United States addiction pharmacotherapy market, currently valued at $2 billion, is expected to reach a value of $2.9 billion by 2012. Over 30 medications are in planning and testing stages to counter alcohol abuse and narcotic and nicotine dependencies. The 41% growth is expected as a result of increased demand for treatment medications that are more tolerable to people who are unable to tolerate currently available therapies. 8.9% of the U.S. population aged 12 or older would meet the diagnostic criteria for a drug or alcohol use disorder (substance use disorder). This was an estimated 22.1 million persons. Of these, 2.9 million were classified with a substance use disorder of both alcohol and illicit drugs. 4.2 million Were classified with a substance use disorder for illicit drugs but not alcohol. 15.0 million Were classified with a substance use disorder for alcohol but not illicit drugs.

USA, specialist mental health settings grew by 61% between 2010 and 2014. USA mental health system, 29% of state and territory mental health spending was dedicated to caring for people in the community by 2014, the share of total mental health expenditure had increased to 53%. National Survey on Drug Use and Health stated that 18.5% of adults with mental illness had a co-occurring substance use disorders, effects 9.98 million people. According to the Drug Abuse, Alcohol, and Mental Health Administration, 60 % of the 2 million populations with severe mental illness addicted to drugs or alcohol, compared to 15 % of the general population. Americans 17 million adults have alcohol use disorders, either alcoholism or other, problems. The cost of those problems to the nation’s economy is $185 billion annually.

Why Munich, Germany?

Munich is one of the major Addiction hubs in Germany. There are about 600 retreat centers in Munich. Prestigious universities of Munich are working in the field of Addiction. It features Best Addiction research centers, Rehabilitation Centers &Counseling Centers, many addiction related Associations and Societies. Top universities of Munich are into addiction research.

Conference Highlights

· Drug Addiction

· Addiction & Brain

· Mental Health & Addiction

· Opioids Poisoning

· Addiction & Neurotoxicology

· Addictive Disorders

· Addiction Psychiatry

· Bipolar Disorders

· Depression & Anxiety

· Clinical Interventions & Case Reports

· Science of Drug abuse

· Neuro Cognitive disorders

· Addiction Nursing

· Addiction: Pharmacology

· Addiction Therapy

· Dual Diagnosis Rehabilitation & Recovery

Why to attend??

With members from around the world focused on learning about Addiction Research and Therapy. The conference brings together some of the latest, most thought-provoking research from around the world. In a small and intimate setting, researchers and clinicians from all corners of the world are able to exchange ideas, share findings and discuss future collaborations. This will produce a broader international knowledge-base and wonderful advances in the field of Addiction Therapy. World-renowned speakers, the most recent techniques, and the newest updates in Addiction research and Therapy are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

Major Addiction Associations and societies around the Globe

· International Society of Addiction Medicine

· National Institute on Drug Abuse

· National Institute on Alcohol Abuse and Alcoholism

· National Association of Alcohol and Drug Abuse Counselors

· National Association of Addiction Treatment Providers

· International Association of Addiction &Offender Counselors

· Canadian Addiction Counselors Certification Federation

· Georgia Addiction Counselors Association

· State association of addiction services

· American Society of Addiction Medicine

· New York Society of Addiction Medicine (NYSAM)

· Munich Alcohol and Drug Abuse Association

· American Academy of Addiction Psychiatry

· Substance abuse and mental health services administration

· Texas Association of Addiction Professionals

· California Society of Addiction Medicine

· California Association of Addiction Recovery Resources

· Care addiction recovery

Top Universities in Munich:

· University of Munich

· Munich State University

· Munich Atlantic University

· University of South Munich

· University of Central Munich

· University of Germany

Rehabilitation Center in Munich, Germany

· Rehabilitationszentrum München

· ZAR Munich center for outpatient rehabilitation

· CITY PHYSIO physiotherapy and rehabilitation

· HELIOS Hospital west of Munich

· CITY PHYSIO physiotherapy and rehabilitation

· Fachambulanz für junge Suchtkranke München

· Anonyme Alkoholiker Kontaktstelle

· Kieferngarten

· Klinik und Poliklinik für Orthopädie, Physikalische Medizin und Rehabilitation

Conference Highlights

Addiction & Brain

Drug Addiction

Mental Health & Addiction

Opioids Poisoning

Addictive Disorders

Addiction & Neurotoxicology

Addiction Psychiatry

Bipolar Disorders

Depression & Anxiety

Clinical Interventions & Case Reports

Science of Drug abuse

Neuro Cognitive disorders

Addiction Nursing

Addiction: Pharmacology

Dual Diagnosis Rehabilitation & Recovery

Addiction Therapy

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date May 18-19, 2017

Sponsors & Exhibitors ~~Click here for Sponsorship Opportunities~~

Speaker Opportunity Closed Day 1 Day 2

Poster Opportunity Closed Click Here to View

Useful Links

Conference Guide

Initial Announcment

Sponsorship Form

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Journal of Addiction Research & Therapy

Journal of Addictive Behaviors, Therapy & Rehabilitation

Journal of Alcoholism and Drug Dependence

Abstracts will be provided with Digital Object Identifier by

2^nd International Conference and Exhibition on Dual Diagnosis May 18-19, 2017 Munich, Germany

Recommended Global Neuroscience Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Dual Diagnosis 2017

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues

Conference Date	May 18-19, 2017
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View